The effect of alcohol on sirt1 expression and function in animal and human models of hepatocellular carcinoma (HCC)

Advances in Experimental Medicine and Biology

Volumn 815, Issue , 2015, Pages 361-373

  Thompson, Kyle J ^a   Humphries, John R ^b   Niemeyer, David J ^a   Sindram, David ^a   McKillop, Iain H ^a,b,c  

^a CAROLINAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^c Molecular Biology Core   (United States)

Author keywords

Ethanol; Hepatocellular carcinoma; HepG2; Sirt1

Indexed keywords

ALCOHOL; CYTOCHROME P450 2E1; SIRTUIN 1; SIRT1 PROTEIN, HUMAN;

ALCOHOL CONSUMPTION; ALCOHOL METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; HEPATOCELLULAR CARCINOMA CELL LINE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR VOLUME; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; ENZYMOLOGY; EXPERIMENTAL LIVER NEOPLASM; LIVER TUMOR; METABOLISM; PHYSIOLOGY; TOXICITY;

ANIMALS; CARCINOMA, HEPATOCELLULAR; ETHANOL; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; SIRTUIN 1;

EID: 84925327886     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-09614-8_21     Document Type: Article

References (49)

1. Siegel R et al (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11-30
2. McKillop IH, Schrum LW (2009) Role of alcohol in liver carcinogenesis. Semin Liver Dis 29(2):222-232
3. Boffetta P et al (2006) The burden of cancer attributable to alcohol drinking. Int J Cancer 119(4):884-887
4. Rehm J et al (2013) Global burden of alcoholic liver diseases. J Hepatol 59(1):160-168
5. International Agency for Research on Cancer (2010) Alcohol consumption and ethyl carba- mate. IARC monographs on the evaluation of carcinogenic risks to humans, vol 96. World Health Organization, Lyon, p 3-1383
6. Bagnardi V et al (2013) Light alcohol drinking and cancer: a meta-analysis. Ann Oncol 24(2):301-308
7. Berman K et al (2011) Hepatic and extrahepatic cancer in cirrhosis: a longitudinal cohort study. Am J Gastroenterol 106(5):899-906
8. Yuan JM et al (2004) Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepato- cellular carcinoma in blacks and whites in the U.S. Cancer 101(5):1009-1017
9. Zakhari S (2006) Overview: how is alcohol metabolized by the body? Alcohol Res Health 29(4):245-254
10. Deitrich RA et al (2007) Removal of acetaldehyde from the body. Novartis Found Symp 285:23-40; discussion 40-51, 198-199
11. Lieber CS (2004) The discovery of the microsomal ethanol oxidizing system and its physio- logic and pathologic role. Drug Metab Rev 36(3-4):511-529
12. Brooks PJ, Theruvathu JA (2005) DNA adducts from acetaldehyde: implications for alcohol- related carcinogenesis. Alcohol 35(3):187-193
13. Seitz HK, Wang XD (2013) The Role of cytochrome P450 2E1 in ethanol-mediated carcinogenesis. Subcell Biochem 67:131-143
14. Sauve AA et al (2006) The biochemistry of sirtuins. Annu Rev Biochem 75:435-465
15. Canto C, Auwerx J (2012) Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)? Pharmacol Rev 64(1):166-187
16. Stunkel W, Campbell RM (2011) Sirtuin 1 (SIRT1): the misunderstood HDAC. J Biomol Screen 16(10):1153-1169
17. You M et al (2008) Mammalian sirtuin 1 is involved in the protective action of dietary saturated fat against alcoholic fatty liver in mice. J Nutr 138(3):497-501
18. You M et al (2008) Involvement of mammalian sirtuin 1 in the action of ethanol in the liver. Am J Physiol Gastrointest Liver Physiol 294(4):G892-G898
19. Lieber CS et al (2008) Effect of chronic alcohol consumption on Hepatic SIRT1 and PGC- 1alpha in rats. Biochem Biophys Res Commun 370(1):44-48
20. Portmann S et al (2013) Antitumor effect of SIRT1 inhibition in human HCC tumor models in vitro and in vivo. Mol Cancer Ther 12(4):499-508
21. Chen J et al (2011) Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth. Cancer Res 71(12):4138-4149
22. Jang KY et al (2012) SIRT1 and c-Myc promote liver tumor cell survival and predict poor survival of human hepatocellular carcinomas. PLoS One 7(9):e45119
23. Lee CW et al (2012) AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells. Cancer Res 72(17):4394-4404
24. Brandon-Warner E et al (2012) Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis. Alcohol Clin Exp Res 36(4):641-653
25. Brandon-Warner E et al (2010) Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma. Cancer Lett 291(1): 120-129
26. Chen Q, Cederbaum AI (1998) Cytotoxicity and apoptosis produced by cytochrome P450 2E1 in Hep G2 cells. Mol Pharmacol 53(4):638-648
27. Osna NA et al (2003) Interferon gamma enhances proteasome activity in recombinant Hep G2 cells that express cytochrome P4502E1: modulation by ethanol. Biochem Pharmacol 66(5): 697-710
28. Clemens DL et al (2002) Relationship between acetaldehyde levels and cell survival in ethanol- metabolizing hepatoma cells. Hepatology 35(5):1196-1204
29. Gertz M et al (2013) Ex-527 inhibits sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism. Proc Natl Acad Sci U S A 110(30):E2772-E2781
30. Nayagam VM et al (2006) SIRT1 modulating compounds from high-throughput screening as anti-inflammatory and insulin-sensitizing agents. J Biomol Screen 11(8):959-967
31. Sokolov E et al (2013) Lysophosphatidic acid receptor expression and function in human hepa- tocellular carcinoma. J Surg Res 180(1):104-113
32. Karaa A et al (2008) S-adenosyl-L-methionine attenuates oxidative stress and hepatic stellate cell activation in an ethanol-LPS-induced fibrotic rat model. Shock 30(2):197-205
33. Sanyal A et al (2010) Population-based risk factors and resource utilization for HCC: US per- spective. Curr Med Res Opin 26(9):2183-2191
34. Kocabayoglu P, Friedman SL (2013) Cellular basis of hepatic fibrosis and its role in inflamma- tion and cancer. Front Biosci (Schol Ed) 5:217-230
35. Schug TT, Li X (2011) Sirtuin 1 in lipid metabolism and obesity. Ann Med 43(3):198-211
36. Liu Y et al (2008) A fasting inducible switch modulates gluconeogenesis via activator/ coactivator exchange. Nature 456(7219):269-273
37. Pfluger PT et al (2008) Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci U S A 105(28):9793-9798
38. Purushotham A et al (2009) Hepatocyte-specific deletion of SIRT1 alters fatty acid metabo- lism and results in hepatic steatosis and inflammation. Cell Metab 9(4):327-338
39. Yeung F et al (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23(12):2369-2380
40. Revollo JR, Li X (2013) The ways and means that fine tune Sirt1 activity. Trends Biochem Sci 38(3):160-167
41. Choi HN et al (2011) Expression and role of SIRT1 in hepatocellular carcinoma. Oncol Rep 26(2):503-510
42. Wang H et al (2012) SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling. Oncol Rep 28(1):311-318
43. Luo J et al (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107(2):137-148
44. Palacios JA et al (2010) SIRT1 contributes to telomere maintenance and augments global homologous recombination. J Cell Biol 191(7):1299-1313
45. Morin PJ et al (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275(5307):1787-1790
46. Levy L et al (2004) Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interac- tion. Mol Cell Biol 24(8):3404-3414
47. Bakkenist CJ, Kastan MB (2003) DNA damage activates ATM through intermolecular auto- phosphorylation and dimer dissociation. Nature 421(6922):499-506
48. Herranz D et al (2010) Sirt1 improves healthy ageing and protects from metabolic syndrome- associated cancer. Nat Commun 1:3
49. Shen Z et al (2009) Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. Am J Physiol Gastrointest Liver Physiol 296(5):G1047-G1053